Optimization of Pharmaceutical R&d Programs and Portfolios PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Optimization of Pharmaceutical R&d Programs and Portfolios PDF full book. Access full book title Optimization of Pharmaceutical R&d Programs and Portfolios by Zoran Antonijevic. Download full books in PDF and EPUB format.
Author: Zoran Antonijevic
Publisher:
ISBN: 9783319090764
Category :
Languages : en
Pages : 212
Get Book Here
Book Description
Author: Zoran Antonijevic
Publisher:
ISBN: 9783319090764
Category :
Languages : en
Pages : 212
Get Book Here
Book Description
Author: H.-Harald Sedlacek
Publisher: John Wiley & Sons
ISBN: 3527615008
Category : Science
Languages : en
Pages : 278
Get Book Here
Book Description
Strategic planning is a critical subject, central to the success of any scientific and economical enterprise. Not only is the scientific knowledge of many persons needed, but also an assessment of what may occur in the future - which approach may be competitive, which option can be achieved, and how can this be accomplished. With a focus on the various ethical obligations to patients, animals and the environment, this book offers hands-on help on how to develop successful R&D strategies, taking special account of the needs of scientists and managers in the pharmaceutical industry. Key topics include: - evaluation and selection of projects - measures to reduce risks - project management - corporate and technology strategy - managing for innovation The reader will learn the methods needed to elaborate strategies so that he or she will become aware of the numerous managerial, organizational, social and political parameters and forces, the consideration of which is essential for the successful realization of a formulated strategy.
Author: Oliver Gassmann
Publisher: Springer Science & Business Media
ISBN: 3540247815
Category : Business & Economics
Languages : en
Pages : 184
Get Book Here
Book Description
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies. The authors focus on three sources of pharmaceutical innovation: new management methods, new technologies, and new forms of internationalization. Their findings are illustrated in the case of the Swiss pharmaceutical industry, the leading exporter of pharmaceutical products in percentage of GDP, and some of its main pharmaceutical firms such as Novartis and Hoffmann-La Roche.
Author: Min Ding
Publisher: Springer Science & Business Media
ISBN: 1461478014
Category : Medical
Languages : en
Pages : 763
Get Book Here
Book Description
The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike.
Author: Bianca Piachaud
Publisher: Springer
ISBN: 0230512631
Category : Business & Economics
Languages : en
Pages : 205
Get Book Here
Book Description
This book examines the strategic aspects of outsourcing in relation to the firm. It provides a holistic view of the outsourcing process, starting with conceptualisation, through to implementation and management of the process. Although the book is based on a case study of the pharmaceutical industry, the general principles derived from the Strategic Sourcing Model are generic in nature and the model can be applied to instances of outsourcing in other industries.
Author: Robert B. Helms
Publisher: A E I Press
ISBN:
Category : Business & Economics
Languages : en
Pages : 408
Get Book Here
Book Description
The growth of government programs and managed care has altered how pharmaceuticals are marketed and sold in the United States. Such change has shortened the expected revenue stream from most products - even though new technologies have increased both the cost and the medical attractiveness of those products. Managers of government and private health care programs are looking for new ways to reduce the cost of drug benefits, while company R&D managers are seeking ways to speed the regulatory process and develop new markets to cover the increasing cost of research. This volume examines various aspects of the continuing policy dispute and offers several views on the future of the pharmaceutical industry.
Author: Roger Dabbah
Publisher: CRC Press
ISBN: 1135458162
Category : Medical
Languages : en
Pages : 944
Get Book Here
Book Description
Drawing on a lifetime of experience, Roger Dobbah gives readers an in-depth view of R&D survival strategies and tactics and demonstrates how to apply them to any organization. The author provides insights into the role of R&D, the crucial topic of creativity and innovation, and the differences and similarities between general management and R&D man
Author: Alexander Schuhmacher
Publisher: John Wiley & Sons
ISBN: 3527339132
Category : Science
Languages : en
Pages : 511
Get Book Here
Book Description
This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.
Author: Sebastian Held
Publisher: BoD – Books on Demand
ISBN: 3936863164
Category :
Languages : en
Pages : 162
Get Book Here
Book Description
Author: David Cavalla
Publisher: John Wiley & Sons
ISBN: 9780471971177
Category : Medical
Languages : en
Pages : 232
Get Book Here
Book Description
The twentieth century has been a great success for modern medicine, and has resulted in the generation of a plethora of drugs to treat most common illnesses. However, in the light of increasing regulatory demands, spiralling costs and diminishing commercial returns, the question of how, when, where and whether to conduct pharmaceutical R&D has profound implications, and not just for those within the pharmaceutical industry. In response to these and other dilemmas, the authors define the processes involved in drug research, and examine the advantages and disadvantages of collaborative methods of drug research, and examine the roles that academia, CROs, small "biotechnology" companies and "research boutiques," and possibly even the "virtual research company" might play as contractors and collaborators.
